Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies
Journal of Personalized Medicine · 10.06.2025 · 15 (6) · 244
DOI: 10.3390/jpm15060244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.06.2025. Verfasst von Fotios Seretis und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Propaedeutic Surgery, Hippokrateion General Hospital of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The rectal cancer treatment paradigm is rapidly changing with the advent of total neoadjuvant therapy and non-operative management approaches in responders. A good clinical response to neoadjuvant treatment documented by magnetic resonance imaging, endoscopy and clinical examination corresponds, to a large extent, to a pathologic complete response, as assessed in surgical specimens.
Methods
We undertook a systematic review and meta-analysis on the MRI-based omics approach to predicting pathologic complete responses.
Results
A total of 29 studies with relevant data available reporting on a total of 4486 patients were eligible for meta-analysis. The calculated values for the area under the curve in receiver operator curves of diagnostic accuracy for radiomics-only and radiomics-combined-with-clinical-data models were 0.80 and 0.88, respectively, for studies incorporating baseline imaging data only. The value for studies using delta radiomic data was 0.86, and those for studies using data from the post-neoadjuvant setting were 0.75 and 0.83, respectively, for the radiomics-only and radiomics-combined-with-clinical-data models.
Conclusions
Radiomics-based prediction models for pathologic complete response assessment might further enable individualized treatment decisions to be made in patients with rectal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Propaedeutic Surgery, Hippokrateion General Hospital of Athens, 11527 Athens, Greece.
- Department of Gastroenterology, "Konstantopouleio" General Hospital of Nea Ionia, 14233 Athens, Greece.
- Department of Radiology, Evangelismos General Hospital of Athens, 10676 Athens, Greece.
- Department of Radiology, "Konstantopouleio" General Hospital of Nea Ionia, 14233 Athens, Greece.
Zitieren
APA
Seretis, F., Panagaki, A., Tzamouri, S., Triantafyllou, T., Triantopoulou, C., & Theodorou, D. (2025). Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies. Journal of Personalized Medicine, 15(6), 244. https://doi.org/10.3390/jpm15060244
Vancouver
Seretis F, Panagaki A, Tzamouri S, Triantafyllou T, Triantopoulou C, Theodorou D. Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies. Journal of Personalized Medicine. 2025;15(6):244. doi:10.3390/jpm15060244
BibTeX
@article{Seretis2025,
author = {Seretis, Fotios and Panagaki, Antonia and Tzamouri, Stavroula and Triantafyllou, Tania and Triantopoulou, Charikleia and Theodorou, Dimitrios},
title = {Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {6},
pages = {244},
doi = {10.3390/jpm15060244}
}
EUVIMED